Anastrozole
Anastrozole, sold under the brand name Arimidex among others, is a drug utilized notwithstanding different therapies for bosom cancer. Explicitly it is utilized for chemical receptor-positive bosom cancer. It has likewise been utilized to forestall bosom malignant growth in those at high risk. It is taken by mouth.
Normal results of anastrozole incorporate hot blazes, modified state of mind, joint agony, and nausea. Serious aftereffects incorporate an expanded gamble of coronary illness and osteoporosis. Use during pregnancy might hurt the baby. Anastrozole is in the aromatase-repressing group of medications. It works by impeding the development of estrogens in the body, and thus has antiestrogenic effects.
Anastrozole was licensed in 1987 and was endorsed for clinical use in 1995. It is on the World Wellbeing Association's Rundown of Fundamental Medicines. Anastrozole is accessible as a nonexclusive medication. In 2019, it was the 176th most usually recommended drug in the US, with multiple million prescriptions.